Glasgow-based SB Drug Discovery announced that it has been acquired by Nottingham-based Sygnature Discovery, an integrated drug discovery firm.

SB Drug Discovery said the transaction will offer a strategic competitive advantage for both companies “to enable further expansion of the businesses and their capabilities” and forms part of Sygnature’s strategic plan to continuously invest in the expansion of its leading integrated drug discovery solutions.